| Board of
Directors and Management Team
BSV is guided by the experience and direction provided
by the Board of Directors, comprising of the following
eminent personalities:
| Dr.
Vinod G Daftary, Chairman Emeritus |
| Mr.
Bharat V. Daftary, Chairman and Managing Director |
| Dr.
Gautam V. Daftary, Managing Director |
| Mr.
Nilesh R Ganjwala, Finance Director |
| Mr.
Shahzaad Dalal, Nominee Director, ILFS Investment
Managers Limited |
| Dr.
Dilip Mehta, Professional Director |
| Mr.
Prakash Shah, Professional Director |
The Board of Directors formulates
the overall business plan and strategy of the Company
and monitors the implementation. The core management
team consisting of senior production, marketing, finance
and research professionals is responsible for the day-to-day
operations of the Company and implementation of the
Company's plans.
Brief
profiles of the Board of Directors:
Dr. Vinod G. Daftary: Dr.
Vinod Daftary founded BSV in 1971, primarily for the
manufacture and marketing of diagnostic and therapeutic
products based on plasma fractions. Given his medical
and scientific background, Dr. Daftary realized the
need for domestic manufacturing of plasma products.
Dr. Vinod Daftary holds a post graduate and doctoral
degree in pathology and microbiology from the Walter
Reed Hospital, Washington DC.
Dr. Daftary has won several academic
and business awards including the Junior Clinical Shirvalkar
Gold Medal for Medicine at G.S. Medical College in 1945,
the DAHANUKAR ENTREPRENEUR AWARD of Maharashtra Chamber
of Commerce for making Anti-D Immuneglobulin for the
first time in India, the Certificate Award for Import
Substitution for making strips for detection of albumin
and glucose in urine and the Import Substitution Award
for making Anti-D serum for the first time in India
by the then Invention Promotion Grant of the Government
of India.
His distinguished and pioneering
efforts in the field of plasma products have also led
to his having several prestigious scientific memberships
like Fellow of the College of American Pathologists,
Fellow of the International College of Surgeons, Member
of the International Academy of Pathologists, Fellow
of the Indian Association of Pathologists & Microbiologists
and Fellow of the Indian College of Pathologists.
Mr. Bharat Daftary: Mr. Bharat
Daftary is the Managing Director of the Company and
is mainly responsible for business strategy, international
alliances, sales and marketing. He has been instrumental
in striking several fruitful international alliances
for BSV and has over the years developed excellent relationships
internationally in the biological and biotech industry.
Dr. Gautam Daftary: A qualified
medical doctor, Dr. Gautam Daftary is the Managing Director
of BSV and spearheads the R&D activities. He also
overseas the manufacturing function of the Company.
He is also credited with starting the first Indian Clinical
Research Company, Siro Clinpharm Private Limited. Dr.
Gautam Daftary's knowledge and expertise in the fields
of microbiology, oncology, allergies, psychiatrics and
infectious diseases has led him to being instrumental
in providing the necessary thrust in R&D at BSV.
Mr. Nilesh
Ganjwala: Mr.Nilesh Ganjwala is a Chartered Accountant
with 18 years of experience in the accounting and financial
consulting profession. He has significant experience
in corporate taxation, systems audit and financial structuring.
Mr. Shahzaad
Dalal: Mr.
Shahzaad Dalal is the Executive Vice Chairman of IL&FS
Investment Managers Limited. Mr Dalal is a Management
Graduate with over 20 years experience.
Prior to assuming this responsibility Mr Dalal was the
CEO of the Asset Management Strategic Business Unit
(ASBU) of IL&FS. He is also on the Board of various
IL&FS group companies such as ORIX Auto Finance
India Ltd., Noida Toll Bridge Company Ltd.,etc. Mr Dalal
was earlier responsible for the overall planning and
raising of resources for IL&FS and project finance
for IL&FS sponsored infrastructure projects. Prior
to joining IL&FS, Mr Dalal was responsible for structured
leasing and hire purchase products, marketing and credit
evaluation with Industrial Credit and Investment Corporation
of India Limited (ICICI).
Dr. Dilip
Mehta: Dr. Dilip Mehta is well known in the pharmaceutical
research sector globally. He has worked with the several
global pharmaceutical companies including Bristol Laboratories
(Clinical Laboratories), Hoechst AG and its subsidiaries
(Group Director, US Clinical Research), Pfizer Inc.
(Sr. Vice President, US Clinical Research), and Quintiles
Spectral (India) Limited (Chairman).
Dr. Dilip Mehta has had more
than fifty scientific publications relating to methodology
of clinical research, pre-clinical work, clinical studies
with cardio-vascular drugs etc, in medical journals
in the India and the US. He is a consultant with various
international committees such as Psychopharmacology
Advisory Committee, FDA, 2002, Scientific Board of Cambridge
Pharmaceuticals, Inc., Verona New Jersey, Scientific
Board of Myomatrix Molecular Technologies LLC, Rensselaer,
New York, Supergen Inc. Dublin, California, Scientific
Board of Advisor and DataEdge Inc. Philadelphia, Scientific
Board of Advisor.
Mr. Prakash
Shah: Mr. Prakash Shah is a senior partner in DSK
Legal and heads the Direct and Indirect Taxation, Litigation
and arbitration practices. A qualified solicitor, Mr.
Shah has specialized in advising on complex issues in
the fields of Direct and Indirect Taxation, Intellectual
Property and General Commercial Litigation. He has provided
strategic legal advice and represented several large
business houses and multinational companies before a
wide variety of fora in diverse legal matters. Mr. Prakash
Shah is an Advocate in the High Court of Bombay, a Solicitor
in the Supreme Court of India and a Solicitor in the
Supreme Court of England and Wales.
|